摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-benzyl 4-(2-fluoro-4-(2-oxo-5-(tosyloxymethyl)oxazolidin-3-yl)phenyl)piperazine-1-carboxylate | 1281885-30-0

中文名称
——
中文别名
——
英文名称
(R)-benzyl 4-(2-fluoro-4-(2-oxo-5-(tosyloxymethyl)oxazolidin-3-yl)phenyl)piperazine-1-carboxylate
英文别名
benzyl 4-[2-fluoro-4-[(5R)-5-[(4-methylphenyl)sulfonyloxymethyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperazine-1-carboxylate
(R)-benzyl 4-(2-fluoro-4-(2-oxo-5-(tosyloxymethyl)oxazolidin-3-yl)phenyl)piperazine-1-carboxylate化学式
CAS
1281885-30-0
化学式
C29H30FN3O7S
mdl
——
分子量
583.638
InChiKey
PYVOUCPCBYMNRJ-XMMPIXPASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    41
  • 可旋转键数:
    9
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    114
  • 氢给体数:
    0
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME<br/>[FR] MÉDICAMENTS CONJUGUÉS À DU PHOSPHATE D'HEXOSE ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
    申请人:PARK JOO YOUN
    公开号:WO2022072425A1
    公开(公告)日:2022-04-07
    A drug conjugate, composition, and method for delivering active antimicrobials based on existing antibiotics through a hexose phosphate transporter (UhpT) by conjugating the antimicrobials with non-metabolizable hexose phosphates. Methods of co-administering antibiotics with non-metabolizable hexose phosphates as antimicrobials are also disclosed. Non-metabolizable hexose phosphates can constitutively and strongly induce expression of UhpT which significantly improves the efficacy and/or antimicrobial spectrum of antibiotics. This drug conjugate, composition and method will permit reuse of many FDA approved antibiotics that have been abandoned or fallen into disuse due to their current low efficacy and/or resistance to these antibiotics by pathogens.
    一种药物结合物、组合物和方法,通过将抗微生物药物与非代谢六糖磷酸酯结合,通过六糖磷酸转运体(UhpT)传递活性抗微生物药物,基于现有抗生素。还公开了联合给予抗生素和非代谢六糖磷酸酯作为抗微生物药物的方法。非代谢六糖磷酸酯可以构成性地和强烈地诱导UhpT的表达,从而显著提高抗生素的功效和/或抗微生物谱。这种药物结合物、组合物和方法将允许重复使用许多已被FDA批准但由于当前低功效和/或病原体对这些抗生素的抗药性而被放弃或停用的抗生素。
  • BORON CONTAINING SMALL MOLECULES
    申请人:HERNANDEZ Vincent S.
    公开号:US20110124597A1
    公开(公告)日:2011-05-26
    This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
    这项发明提供了多种新型化合物,用于治疗细菌感染,包括含有这些化合物的药物组合物,以及这些化合物与至少一种其他治疗有效剂的组合。
  • An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants
    作者:Wanida Phetsang、Mark A.T. Blaskovich、Mark S. Butler、Johnny X. Huang、Johannes Zuegg、Sreeman K. Mamidyala、Soumya Ramu、Angela M. Kavanagh、Matthew A. Cooper
    DOI:10.1016/j.bmc.2014.05.054
    日期:2014.8
    An azide-functionalised analogue of the oxazolidinone antibiotic linezolid was synthesised and shown to retain antimicrobial activity. Using facile 'click' chemistry, this versatile intermediate can be further functionalised to explore antimicrobial structure-activity relationships or conjugated to fluorophores to generate fluorescent probes. Such probes can report bacteria and their location in a sample in real time. Modelling of the structures bound to the cognate 50S ribosome target demonstrates binding to the same site as linezolid is possible. The fluorescent probes were successfully used to image Gram-positive bacteria using confocal microscopy.
  • [EN] BORON CONTAINING SMALL MOLECULES<br/>[FR] PETITES MOLÉCULES CONTENANT DU BORE
    申请人:ANACOR PHARMACEUTICALS INC
    公开号:WO2011037731A1
    公开(公告)日:2011-03-31
    This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
    这项发明提供了用于治疗细菌感染的新化合物,包含这些化合物的药物组合物,以及这些化合物与至少一种其他治疗有效剂的组合。
查看更多